Search Results - "Wilson J Ribot"

Refine Results
  1. 1

    Cluster 1 Type VI Secretion System Is a Major Virulence Determinant in Burkholderia pseudomallei by Burtnick, Mary N, Brett, Paul J, Harding, Sarah V, Ngugi, Sarah A, Ribot, Wilson J, Chantratita, Narisara, Scorpio, Angelo, Milne, Timothy S, Dean, Rachel E, Fritz, David L, Peacock, Sharon J, Prior, Joanne L, Atkins, Timothy P, DeShazer, David

    Published in Infection and Immunity (01-04-2011)
    “…The Burkholderia pseudomallei K96243 genome encodes six type VI secretion systems (T6SSs), but little is known about the role of these systems in the biology…”
    Get full text
    Journal Article
  2. 2

    Type VI secretion is a major virulence determinant in Burkholderia mallei by Schell, Mark A, Ulrich, Ricky L, Ribot, Wilson J, Brueggemann, Ernst E, Hines, Harry B, Chen, Dan, Lipscomb, Lyla, Kim, H. Stanley, Mrázek, Jan, Nierman, William C, DeShazer, David

    Published in Molecular microbiology (01-06-2007)
    “…Burkholderia mallei is a host-adapted pathogen and a category B biothreat agent. Although the B. mallei VirAG two-component regulatory system is required for…”
    Get full text
    Journal Article
  3. 3

    The capsule of Bacillus anthracis protects it from the bactericidal activity of human defensins and other cationic antimicrobial peptides by O'Brien, David K, Ribot, Wilson J, Chabot, Donald J, Scorpio, Angelo, Tobery, Steven A, Jelacic, Tanya M, Wu, Zhibin, Friedlander, Arthur M

    Published in PLoS pathogens (29-09-2022)
    “…During infection, Bacillus anthracis bacilli encounter potent antimicrobial peptides (AMPs) such as defensins. We examined the role that B . anthracis capsule…”
    Get full text
    Journal Article
  4. 4

    The Madagascar hissing cockroach as a novel surrogate host for Burkholderia pseudomallei, B. mallei and B. thailandensis by Fisher, Nathan A, Ribot, Wilson J, Applefeld, Willard, DeShazer, David

    Published in BMC microbiology (22-06-2012)
    “…Burkholderia pseudomallei and Burkholderia mallei are gram-negative pathogens responsible for the diseases melioidosis and glanders, respectively. Both species…”
    Get full text
    Journal Article
  5. 5

    Treatment of Experimental Anthrax with Recombinant Capsule Depolymerase by SCORPIO, Angelo, TOBERY, Steven A, RIBOT, Wilson J, FRIEDLANDER, Arthur M

    Published in Antimicrobial Agents and Chemotherapy (01-03-2008)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  6. 6

    Burkholderia mallei tssM Encodes a Putative Deubiquitinase That Is Secreted and Expressed inside Infected RAW 264.7 Murine Macrophages by Shanks, John, Burtnick, Mary N, Brett, Paul J, Waag, David M, Spurgers, Kevin B, Ribot, Wilson J, Schell, Mark A, Panchal, Rekha G, Gherardini, Frank C, Wilkinson, Keith D, DeShazer, David

    Published in Infection and Immunity (01-04-2009)
    “…Burkholderia mallei, a category B biothreat agent, is a facultative intracellular pathogen that causes the zoonotic disease glanders. The B. mallei VirAG…”
    Get full text
    Journal Article
  7. 7

    Animal Pathogen-Like Type III Secretion System Is Required for the Intracellular Survival of Burkholderia mallei within J774.2 Macrophages by Ribot, Wilson J, Ulrich, Ricky L

    Published in Infection and Immunity (01-07-2006)
    “…Burkholderia mallei is a highly infectious gram-negative pathogen and is the causative agent of human and animal glanders. By generating polar mutations…”
    Get full text
    Journal Article
  8. 8

    Time-Lapse Confocal Imaging of Development of Bacillus anthracis in Macrophages by Ruthel, Gordon, Ribot, Wilson J., Bavari, Sina, Hoover, Timothy A.

    Published in The Journal of infectious diseases (01-04-2004)
    “…Macrophages attempt to battle infection with Bacillus anthracis spores by phagocytosis of the spores. However, it is believed that B. anthracis spores may…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Anthrax Lethal Toxin Impairs Innate Immune Functions of Alveolar Macrophages and Facilitates Bacillus anthracis Survival by Ribot, Wilson J, Panchal, Rekha G, Brittingham, Katherine C, Ruthel, Gordon, Kenny, Tara A, Lane, Douglas, Curry, Bob, Hoover, Timothy A, Friedlander, Arthur M, Bavari, Sina

    Published in Infection and Immunity (01-09-2006)
    “…Alveolar macrophages (AM) are very important for pulmonary innate immune responses against invading inhaled pathogens because they directly kill the organisms…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Activity of the Bacillus anthracis 20 kDa protective antigen component by Hammamieh, Rasha, Ribot, Wilson J, Abshire, Terry G, Jett, Marti, Ezzell, John

    Published in BMC infectious diseases (22-09-2008)
    “…Anthrax is caused by Bacillus anthracis that produce two exotoxins, lethal toxin and edema toxin. The lethal toxin is composed of the lethal factor (LF)…”
    Get full text
    Journal Article
  13. 13

    Human Innate Immune Cells Respond Differentially to Poly-γ-Glutamic Acid Polymers from Bacillus anthracis and Nonpathogenic Bacillus Species by Jelacic, Tanya M, Ribot, Wilson J, Chua, Jennifer, Boyer, Anne E, Woolfitt, Adrian R, Barr, John R, Friedlander, Arthur M

    Published in The Journal of immunology (1950) (01-03-2020)
    “…The poly-γ-glutamic acid (PGA) capsule produced by is composed entirely of d-isomer glutamic acid, whereas nonpathogenic species produce mixed d-, l-isomer…”
    Get full text
    Journal Article
  14. 14

    In vitro intracellular trafficking of virulence antigen during infection by Yersinia pestis by DiMezzo, Tracy L, Ruthel, Gordon, Brueggemann, Ernst E, Hines, Harry B, Ribot, Wilson J, Chapman, Carol E, Powell, Bradford S, Welkos, Susan L

    Published in PloS one (17-07-2009)
    “…Yersinia pestis, the causative agent of plague, encodes several essential virulence factors on a 70 kb plasmid, including the Yersinia outer proteins (Yops)…”
    Get full text
    Journal Article
  15. 15

    Protection of rhesus macaques against inhalational anthrax with a Bacillus anthracis capsule conjugate vaccine by Chabot, Donald J, Ribot, Wilson J, Joyce, Joseph, Cook, James, Hepler, Robert, Nahas, Debbie, Chua, Jennifer, Friedlander, Arthur M

    Published in Vaccine (25-07-2016)
    “…Abstract The efficacy of currently licensed anthrax vaccines is largely attributable to a single Bacillus anthracis immunogen, protective antigen. To broaden…”
    Get full text
    Journal Article
  16. 16

    Poly-γ-Glutamic Acid Encapsulation of Bacillus anthracis Inhibits Human Dendritic Cell Responses by Jelacic, Tanya M, Ribot, Wilson J, Tobery, Steven A, Chabot, Donald J, Friedlander, Arthur M

    Published in ImmunoHorizons (09-02-2021)
    “…The capsule of is composed of a d isomer poly-γ-glutamic acid polymer, which is especially nonstimulatory to dendritic cells, even more so than similar mixed…”
    Get full text
    Journal Article
  17. 17

    Dendritic Cells Endocytose Bacillus anthracis Spores: Implications for Anthrax Pathogenesis by Brittingham, Katherine C, Ruthel, Gordon, Panchal, Rekha G, Fuller, Claudette L, Ribot, Wilson J, Hoover, Timothy A, Young, Howard A, Anderson, Arthur O, Bavari, Sina

    Published in The Journal of immunology (1950) (01-05-2005)
    “…Phagocytosis of inhaled Bacillus anthracis spores and subsequent trafficking to lymph nodes are decisive events in the progression of inhalational anthrax…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Activity of the Bacillus anthracis20 kDa protective antigen component by Hammamieh, Rasha, Ribot, Wilson J, Abshire, Terry G, Jett, Marti, Ezzell, John

    Published in BMC infectious diseases (22-09-2008)
    “…Abstract Background Anthrax is caused by Bacillus anthracis that produce two exotoxins, lethal toxin and edema toxin. The lethal toxin is composed of the…”
    Get full text
    Journal Article